We also show forecasts for contract services by therapeutic area:
• Central nervous system (CNS) diseases
• Cardiovascular diseases
• Metabolic disorders
• Other therapy areas (grouped prediction).
You gain advantages by understanding trends, opportunities and challenges. Our investigation shows what will stimulate and restrain business for CROs.
Our work also breaks the main world forecast into geographical markets.
What prospects for leading regions and countries? Developments worldwide will influence the market from 2013, especially improving clinical research in developing countries. There exist many opportunities for pharmaceutical companies and contract research providers. See outlooks for clinical testing.
You get individual forecasts to 2023 for 12 national markets and two regional groups, finding overall revenues:• US• Japan• Western Europe• Central and Eastern Europe (CEE)• Germany, France, UK, Italy and Spain (EU5)• Brazil, Russia, India and China (BRIC nations) and South Korea.
Discover progress and outlooks. You assess the industry's future - hear about developments and find their significance. Our work explains, exploring many issues.
What affects clinical trial services from 2013? Our report discusses issues and events affecting that industry and market from 2013:
• Future of outsourced phase I, II and III trials and post-marketing studies
• Demand from pharmaceutical and biopharma companies
• Regulatory policy
• Challenges in developed and developing countri
Copyright©2012 PR Newswire.
All rights reserved